nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—hematologic cancer	0.252	0.447	CbGbCtD
Tetrabenazine—CYP2D6—Lomustine—hematologic cancer	0.059	0.104	CbGbCtD
Tetrabenazine—CYP2D6—Idarubicin—hematologic cancer	0.0525	0.0931	CbGbCtD
Tetrabenazine—CYP2D6—Hydroxyurea—hematologic cancer	0.0447	0.0791	CbGbCtD
Tetrabenazine—CYP2D6—Bortezomib—hematologic cancer	0.0389	0.0688	CbGbCtD
Tetrabenazine—CYP2D6—Imatinib—hematologic cancer	0.0285	0.0504	CbGbCtD
Tetrabenazine—CYP2D6—Nilotinib—hematologic cancer	0.0259	0.0458	CbGbCtD
Tetrabenazine—CYP2D6—Vinorelbine—hematologic cancer	0.0257	0.0455	CbGbCtD
Tetrabenazine—CYP2D6—Vinblastine—hematologic cancer	0.0158	0.028	CbGbCtD
Tetrabenazine—CYP2D6—Dexamethasone—hematologic cancer	0.0117	0.0207	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—hematologic cancer	0.00972	0.0172	CbGbCtD
Tetrabenazine—SLC18A2—hematopoietic system—hematologic cancer	0.00331	0.115	CbGeAlD
Tetrabenazine—CBR1—gonad—hematologic cancer	0.00293	0.101	CbGeAlD
Tetrabenazine—CBR1—blood—hematologic cancer	0.00255	0.0883	CbGeAlD
Tetrabenazine—CBR1—bone marrow—hematologic cancer	0.00247	0.0854	CbGeAlD
Tetrabenazine—CBR1—lung—hematologic cancer	0.00224	0.0774	CbGeAlD
Tetrabenazine—SLC18A2—blood—hematologic cancer	0.00219	0.0759	CbGeAlD
Tetrabenazine—CBR1—testis—hematologic cancer	0.00211	0.073	CbGeAlD
Tetrabenazine—SLC18A2—lung—hematologic cancer	0.00192	0.0665	CbGeAlD
Tetrabenazine—SLC18A2—testis—hematologic cancer	0.00181	0.0628	CbGeAlD
Tetrabenazine—CBR1—lymph node—hematologic cancer	0.00153	0.0529	CbGeAlD
Tetrabenazine—CBR1—Vincristine—Vinorelbine—hematologic cancer	0.0014	0.201	CbGdCrCtD
Tetrabenazine—SLC18A2—lymph node—hematologic cancer	0.00131	0.0455	CbGeAlD
Tetrabenazine—CBR1—Vincristine—Vinblastine—hematologic cancer	0.00112	0.16	CbGdCrCtD
Tetrabenazine—CYP2D6—hematopoietic system—hematologic cancer	0.00111	0.0383	CbGeAlD
Tetrabenazine—DRD2—lung—hematologic cancer	0.00107	0.037	CbGeAlD
Tetrabenazine—DRD2—testis—hematologic cancer	0.00101	0.0349	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Pentostatin—hematologic cancer	0.000854	0.122	CbGdCrCtD
Tetrabenazine—CBR1—Azacitidine—Clofarabine—hematologic cancer	0.000761	0.109	CbGdCrCtD
Tetrabenazine—CYP2D6—blood—hematologic cancer	0.000733	0.0254	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Nelarabine—hematologic cancer	0.000715	0.103	CbGdCrCtD
Tetrabenazine—CYP2D6—testis—hematologic cancer	0.000606	0.021	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Fludarabine—hematologic cancer	0.000558	0.08	CbGdCrCtD
Tetrabenazine—CBR1—Azacitidine—Cytarabine—hematologic cancer	0.000527	0.0756	CbGdCrCtD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—hematologic cancer	0.000527	0.0756	CbGdCrCtD
Tetrabenazine—CBR1—Azacitidine—Cladribine—hematologic cancer	0.000514	0.0737	CbGdCrCtD
Tetrabenazine—Bronchitis—Epirubicin—hematologic cancer	0.000121	0.000341	CcSEcCtD
Tetrabenazine—Eye disorder—Prednisone—hematologic cancer	0.00012	0.000339	CcSEcCtD
Tetrabenazine—Vomiting—Bleomycin—hematologic cancer	0.00012	0.000339	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—hematologic cancer	0.00012	0.000338	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—hematologic cancer	0.000119	0.000337	CcSEcCtD
Tetrabenazine—Headache—Bortezomib—hematologic cancer	0.000119	0.000337	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—hematologic cancer	0.000119	0.000336	CcSEcCtD
Tetrabenazine—Asthenia—Carmustine—hematologic cancer	0.000118	0.000334	CcSEcCtD
Tetrabenazine—Vomiting—Vinorelbine—hematologic cancer	0.000118	0.000334	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—hematologic cancer	0.000118	0.000333	CcSEcCtD
Tetrabenazine—Dry mouth—Triamcinolone—hematologic cancer	0.000118	0.000333	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—hematologic cancer	0.000117	0.000332	CcSEcCtD
Tetrabenazine—Diarrhoea—Thalidomide—hematologic cancer	0.000117	0.000332	CcSEcCtD
Tetrabenazine—Dizziness—Thiotepa—hematologic cancer	0.000117	0.000331	CcSEcCtD
Tetrabenazine—Asthenia—Alitretinoin—hematologic cancer	0.000117	0.000331	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000117	0.00033	CcSEcCtD
Tetrabenazine—Angiopathy—Prednisone—hematologic cancer	0.000117	0.00033	CcSEcCtD
Tetrabenazine—Headache—Vinorelbine—hematologic cancer	0.000116	0.000329	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—hematologic cancer	0.000116	0.000328	CcSEcCtD
Tetrabenazine—Asthenia—Ifosfamide—hematologic cancer	0.000116	0.000327	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—hematologic cancer	0.000115	0.000324	CcSEcCtD
Tetrabenazine—Feeling abnormal—Cisplatin—hematologic cancer	0.000115	0.000324	CcSEcCtD
Tetrabenazine—Insomnia—Prednisolone—hematologic cancer	0.000114	0.000321	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—hematologic cancer	0.000114	0.000321	CcSEcCtD
Tetrabenazine—Dizziness—Thalidomide—hematologic cancer	0.000113	0.000321	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—hematologic cancer	0.000113	0.00032	CcSEcCtD
Tetrabenazine—Nausea—Bortezomib—hematologic cancer	0.000113	0.000319	CcSEcCtD
Tetrabenazine—Asthenia—Vincristine—hematologic cancer	0.000113	0.000319	CcSEcCtD
Tetrabenazine—Vomiting—Thiotepa—hematologic cancer	0.000113	0.000319	CcSEcCtD
Tetrabenazine—Diarrhoea—Carmustine—hematologic cancer	0.000113	0.000319	CcSEcCtD
Tetrabenazine—Mental disorder—Prednisone—hematologic cancer	0.000113	0.000318	CcSEcCtD
Tetrabenazine—Nausea—Bleomycin—hematologic cancer	0.000112	0.000317	CcSEcCtD
Tetrabenazine—Drowsiness—Epirubicin—hematologic cancer	0.000112	0.000316	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—hematologic cancer	0.000112	0.000316	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000112	0.000316	CcSEcCtD
Tetrabenazine—Diarrhoea—Alitretinoin—hematologic cancer	0.000112	0.000316	CcSEcCtD
Tetrabenazine—Headache—Thiotepa—hematologic cancer	0.000111	0.000314	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—hematologic cancer	0.000111	0.000313	CcSEcCtD
Tetrabenazine—Diarrhoea—Ifosfamide—hematologic cancer	0.00011	0.000312	CcSEcCtD
Tetrabenazine—Nausea—Vinorelbine—hematologic cancer	0.00011	0.000312	CcSEcCtD
Tetrabenazine—Body temperature increased—Cisplatin—hematologic cancer	0.00011	0.000311	CcSEcCtD
Tetrabenazine—Asthenia—Irinotecan—hematologic cancer	0.00011	0.000311	CcSEcCtD
Tetrabenazine—Asthenia—Mitoxantrone—hematologic cancer	0.00011	0.000311	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—hematologic cancer	0.00011	0.00031	CcSEcCtD
Tetrabenazine—Vomiting—Thalidomide—hematologic cancer	0.000109	0.000308	CcSEcCtD
Tetrabenazine—Anxiety—Dexamethasone—hematologic cancer	0.000109	0.000308	CcSEcCtD
Tetrabenazine—Anxiety—Betamethasone—hematologic cancer	0.000109	0.000308	CcSEcCtD
Tetrabenazine—Dizziness—Carmustine—hematologic cancer	0.000109	0.000308	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—hematologic cancer	0.000109	0.000308	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—hematologic cancer	0.000109	0.000307	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000108	0.000305	CcSEcCtD
Tetrabenazine—Dizziness—Alitretinoin—hematologic cancer	0.000108	0.000305	CcSEcCtD
Tetrabenazine—Diarrhoea—Vincristine—hematologic cancer	0.000108	0.000304	CcSEcCtD
Tetrabenazine—Headache—Thalidomide—hematologic cancer	0.000107	0.000304	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—hematologic cancer	0.000107	0.000303	CcSEcCtD
Tetrabenazine—Asthenia—Gemcitabine—hematologic cancer	0.000107	0.000302	CcSEcCtD
Tetrabenazine—Dizziness—Ifosfamide—hematologic cancer	0.000107	0.000301	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—hematologic cancer	0.000106	0.0003	CcSEcCtD
Tetrabenazine—Nausea—Thiotepa—hematologic cancer	0.000105	0.000298	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—hematologic cancer	0.000105	0.000298	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—hematologic cancer	0.000105	0.000297	CcSEcCtD
Tetrabenazine—Diarrhoea—Irinotecan—hematologic cancer	0.000105	0.000296	CcSEcCtD
Tetrabenazine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000105	0.000296	CcSEcCtD
Tetrabenazine—Vomiting—Carmustine—hematologic cancer	0.000105	0.000296	CcSEcCtD
Tetrabenazine—Insomnia—Triamcinolone—hematologic cancer	0.000104	0.000295	CcSEcCtD
Tetrabenazine—Dizziness—Vincristine—hematologic cancer	0.000104	0.000294	CcSEcCtD
Tetrabenazine—Vomiting—Alitretinoin—hematologic cancer	0.000104	0.000293	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—hematologic cancer	0.000104	0.000293	CcSEcCtD
Tetrabenazine—Feeling abnormal—Prednisolone—hematologic cancer	0.000103	0.000293	CcSEcCtD
Tetrabenazine—Headache—Carmustine—hematologic cancer	0.000103	0.000292	CcSEcCtD
Tetrabenazine—Dyspnoea—Triamcinolone—hematologic cancer	0.000103	0.000291	CcSEcCtD
Tetrabenazine—Nervous system disorder—Dexamethasone—hematologic cancer	0.000103	0.000291	CcSEcCtD
Tetrabenazine—Nervous system disorder—Betamethasone—hematologic cancer	0.000103	0.000291	CcSEcCtD
Tetrabenazine—Agitation—Prednisone—hematologic cancer	0.000103	0.000291	CcSEcCtD
Tetrabenazine—Vomiting—Ifosfamide—hematologic cancer	0.000102	0.00029	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—hematologic cancer	0.000102	0.000289	CcSEcCtD
Tetrabenazine—Headache—Alitretinoin—hematologic cancer	0.000102	0.000289	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—hematologic cancer	0.000102	0.000288	CcSEcCtD
Tetrabenazine—Nausea—Thalidomide—hematologic cancer	0.000102	0.000288	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000101	0.000286	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000101	0.000286	CcSEcCtD
Tetrabenazine—Dizziness—Irinotecan—hematologic cancer	0.000101	0.000286	CcSEcCtD
Tetrabenazine—Body temperature increased—Etoposide—hematologic cancer	0.000101	0.000285	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—hematologic cancer	0.0001	0.000284	CcSEcCtD
Tetrabenazine—Vomiting—Vincristine—hematologic cancer	9.99e-05	0.000283	CcSEcCtD
Tetrabenazine—Asthenia—Cisplatin—hematologic cancer	9.97e-05	0.000282	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—hematologic cancer	9.96e-05	0.000282	CcSEcCtD
Tetrabenazine—Fatigue—Triamcinolone—hematologic cancer	9.96e-05	0.000282	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—hematologic cancer	9.93e-05	0.000281	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—hematologic cancer	9.92e-05	0.000281	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—hematologic cancer	9.85e-05	0.000278	CcSEcCtD
Tetrabenazine—Headache—Vincristine—hematologic cancer	9.85e-05	0.000278	CcSEcCtD
Tetrabenazine—Hypotension—Betamethasone—hematologic cancer	9.79e-05	0.000277	CcSEcCtD
Tetrabenazine—Hypotension—Dexamethasone—hematologic cancer	9.79e-05	0.000277	CcSEcCtD
Tetrabenazine—Nausea—Carmustine—hematologic cancer	9.78e-05	0.000277	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—hematologic cancer	9.74e-05	0.000275	CcSEcCtD
Tetrabenazine—Vomiting—Irinotecan—hematologic cancer	9.73e-05	0.000275	CcSEcCtD
Tetrabenazine—Vomiting—Mitoxantrone—hematologic cancer	9.73e-05	0.000275	CcSEcCtD
Tetrabenazine—Nausea—Alitretinoin—hematologic cancer	9.69e-05	0.000274	CcSEcCtD
Tetrabenazine—Headache—Mitoxantrone—hematologic cancer	9.59e-05	0.000271	CcSEcCtD
Tetrabenazine—Headache—Irinotecan—hematologic cancer	9.59e-05	0.000271	CcSEcCtD
Tetrabenazine—Nausea—Ifosfamide—hematologic cancer	9.58e-05	0.000271	CcSEcCtD
Tetrabenazine—Feeling abnormal—Triamcinolone—hematologic cancer	9.52e-05	0.000269	CcSEcCtD
Tetrabenazine—Diarrhoea—Cisplatin—hematologic cancer	9.51e-05	0.000269	CcSEcCtD
Tetrabenazine—Anxiety—Prednisone—hematologic cancer	9.49e-05	0.000268	CcSEcCtD
Tetrabenazine—Vomiting—Gemcitabine—hematologic cancer	9.48e-05	0.000268	CcSEcCtD
Tetrabenazine—Insomnia—Betamethasone—hematologic cancer	9.48e-05	0.000268	CcSEcCtD
Tetrabenazine—Insomnia—Dexamethasone—hematologic cancer	9.48e-05	0.000268	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—hematologic cancer	9.46e-05	0.000268	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.45e-05	0.000267	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—hematologic cancer	9.4e-05	0.000266	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—hematologic cancer	9.39e-05	0.000265	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—hematologic cancer	9.34e-05	0.000264	CcSEcCtD
Tetrabenazine—Nausea—Vincristine—hematologic cancer	9.34e-05	0.000264	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—hematologic cancer	9.32e-05	0.000264	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—hematologic cancer	9.18e-05	0.00026	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—hematologic cancer	9.14e-05	0.000258	CcSEcCtD
Tetrabenazine—Body temperature increased—Triamcinolone—hematologic cancer	9.13e-05	0.000258	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—hematologic cancer	9.11e-05	0.000258	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—hematologic cancer	9.11e-05	0.000258	CcSEcCtD
Tetrabenazine—Decreased appetite—Dexamethasone—hematologic cancer	9.11e-05	0.000258	CcSEcCtD
Tetrabenazine—Decreased appetite—Betamethasone—hematologic cancer	9.11e-05	0.000258	CcSEcCtD
Tetrabenazine—Nausea—Mitoxantrone—hematologic cancer	9.09e-05	0.000257	CcSEcCtD
Tetrabenazine—Nausea—Irinotecan—hematologic cancer	9.09e-05	0.000257	CcSEcCtD
Tetrabenazine—Fatigue—Dexamethasone—hematologic cancer	9.03e-05	0.000255	CcSEcCtD
Tetrabenazine—Fatigue—Betamethasone—hematologic cancer	9.03e-05	0.000255	CcSEcCtD
Tetrabenazine—Nervous system disorder—Prednisone—hematologic cancer	8.95e-05	0.000253	CcSEcCtD
Tetrabenazine—Skin disorder—Prednisone—hematologic cancer	8.86e-05	0.000251	CcSEcCtD
Tetrabenazine—Nausea—Gemcitabine—hematologic cancer	8.86e-05	0.00025	CcSEcCtD
Tetrabenazine—Vomiting—Cisplatin—hematologic cancer	8.84e-05	0.00025	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Prednisone—hematologic cancer	8.82e-05	0.000249	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—hematologic cancer	8.8e-05	0.000249	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—hematologic cancer	8.71e-05	0.000246	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—hematologic cancer	8.69e-05	0.000246	CcSEcCtD
Tetrabenazine—Feeling abnormal—Dexamethasone—hematologic cancer	8.63e-05	0.000244	CcSEcCtD
Tetrabenazine—Feeling abnormal—Betamethasone—hematologic cancer	8.63e-05	0.000244	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—hematologic cancer	8.63e-05	0.000244	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—hematologic cancer	8.58e-05	0.000243	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—hematologic cancer	8.49e-05	0.00024	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—hematologic cancer	8.43e-05	0.000238	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—hematologic cancer	8.42e-05	0.000238	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—hematologic cancer	8.36e-05	0.000237	CcSEcCtD
Tetrabenazine—Dizziness—Prednisolone—hematologic cancer	8.3e-05	0.000235	CcSEcCtD
Tetrabenazine—Asthenia—Triamcinolone—hematologic cancer	8.29e-05	0.000234	CcSEcCtD
Tetrabenazine—Body temperature increased—Betamethasone—hematologic cancer	8.28e-05	0.000234	CcSEcCtD
Tetrabenazine—Body temperature increased—Dexamethasone—hematologic cancer	8.28e-05	0.000234	CcSEcCtD
Tetrabenazine—Nausea—Cisplatin—hematologic cancer	8.26e-05	0.000233	CcSEcCtD
Tetrabenazine—Insomnia—Prednisone—hematologic cancer	8.25e-05	0.000233	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—hematologic cancer	8.14e-05	0.00023	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—hematologic cancer	8.1e-05	0.000229	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—hematologic cancer	8.04e-05	0.000227	CcSEcCtD
Tetrabenazine—Headache—Etoposide—hematologic cancer	7.98e-05	0.000226	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—hematologic cancer	7.94e-05	0.000225	CcSEcCtD
Tetrabenazine—Decreased appetite—Prednisone—hematologic cancer	7.93e-05	0.000224	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.9e-05	0.000223	CcSEcCtD
Tetrabenazine—Fatigue—Prednisone—hematologic cancer	7.87e-05	0.000222	CcSEcCtD
Tetrabenazine—Headache—Prednisolone—hematologic cancer	7.87e-05	0.000222	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—hematologic cancer	7.86e-05	0.000222	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—hematologic cancer	7.83e-05	0.000221	CcSEcCtD
Tetrabenazine—Constipation—Prednisone—hematologic cancer	7.8e-05	0.000221	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—hematologic cancer	7.69e-05	0.000217	CcSEcCtD
Tetrabenazine—Dizziness—Triamcinolone—hematologic cancer	7.64e-05	0.000216	CcSEcCtD
Tetrabenazine—Nausea—Etoposide—hematologic cancer	7.56e-05	0.000214	CcSEcCtD
Tetrabenazine—Feeling abnormal—Prednisone—hematologic cancer	7.52e-05	0.000213	CcSEcCtD
Tetrabenazine—Asthenia—Betamethasone—hematologic cancer	7.52e-05	0.000213	CcSEcCtD
Tetrabenazine—Asthenia—Dexamethasone—hematologic cancer	7.52e-05	0.000213	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—hematologic cancer	7.48e-05	0.000211	CcSEcCtD
Tetrabenazine—Nausea—Prednisolone—hematologic cancer	7.46e-05	0.000211	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—hematologic cancer	7.44e-05	0.00021	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—hematologic cancer	7.42e-05	0.00021	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—hematologic cancer	7.41e-05	0.000209	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.39e-05	0.000209	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—hematologic cancer	7.37e-05	0.000208	CcSEcCtD
Tetrabenazine—Vomiting—Triamcinolone—hematologic cancer	7.34e-05	0.000208	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—hematologic cancer	7.28e-05	0.000206	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—hematologic cancer	7.24e-05	0.000205	CcSEcCtD
Tetrabenazine—Headache—Triamcinolone—hematologic cancer	7.23e-05	0.000205	CcSEcCtD
Tetrabenazine—Body temperature increased—Prednisone—hematologic cancer	7.21e-05	0.000204	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—hematologic cancer	7.2e-05	0.000203	CcSEcCtD
Tetrabenazine—Diarrhoea—Betamethasone—hematologic cancer	7.17e-05	0.000203	CcSEcCtD
Tetrabenazine—Diarrhoea—Dexamethasone—hematologic cancer	7.17e-05	0.000203	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—hematologic cancer	7.13e-05	0.000202	CcSEcCtD
Tetrabenazine—Nervous system disorder—Epirubicin—hematologic cancer	7e-05	0.000198	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—hematologic cancer	6.93e-05	0.000196	CcSEcCtD
Tetrabenazine—Dizziness—Betamethasone—hematologic cancer	6.93e-05	0.000196	CcSEcCtD
Tetrabenazine—Dizziness—Dexamethasone—hematologic cancer	6.93e-05	0.000196	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—hematologic cancer	6.9e-05	0.000195	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—hematologic cancer	6.9e-05	0.000195	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—hematologic cancer	6.86e-05	0.000194	CcSEcCtD
Tetrabenazine—Nausea—Triamcinolone—hematologic cancer	6.86e-05	0.000194	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.84e-05	0.000193	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—hematologic cancer	6.8e-05	0.000192	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—hematologic cancer	6.78e-05	0.000192	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—hematologic cancer	6.74e-05	0.000191	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—hematologic cancer	6.67e-05	0.000189	CcSEcCtD
Tetrabenazine—Vomiting—Dexamethasone—hematologic cancer	6.66e-05	0.000188	CcSEcCtD
Tetrabenazine—Vomiting—Betamethasone—hematologic cancer	6.66e-05	0.000188	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—hematologic cancer	6.66e-05	0.000188	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—hematologic cancer	6.63e-05	0.000187	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—hematologic cancer	6.58e-05	0.000186	CcSEcCtD
Tetrabenazine—Headache—Betamethasone—hematologic cancer	6.56e-05	0.000186	CcSEcCtD
Tetrabenazine—Headache—Dexamethasone—hematologic cancer	6.56e-05	0.000186	CcSEcCtD
Tetrabenazine—Asthenia—Prednisone—hematologic cancer	6.55e-05	0.000185	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—hematologic cancer	6.48e-05	0.000183	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—hematologic cancer	6.46e-05	0.000183	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—hematologic cancer	6.41e-05	0.000181	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—hematologic cancer	6.38e-05	0.000181	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—hematologic cancer	6.36e-05	0.00018	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—hematologic cancer	6.34e-05	0.000179	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—hematologic cancer	6.28e-05	0.000178	CcSEcCtD
Tetrabenazine—Diarrhoea—Prednisone—hematologic cancer	6.24e-05	0.000177	CcSEcCtD
Tetrabenazine—Nausea—Dexamethasone—hematologic cancer	6.22e-05	0.000176	CcSEcCtD
Tetrabenazine—Nausea—Betamethasone—hematologic cancer	6.22e-05	0.000176	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—hematologic cancer	6.2e-05	0.000175	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—hematologic cancer	6.17e-05	0.000174	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—hematologic cancer	6.15e-05	0.000174	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—hematologic cancer	6.1e-05	0.000173	CcSEcCtD
Tetrabenazine—Dizziness—Prednisone—hematologic cancer	6.03e-05	0.000171	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—hematologic cancer	6.03e-05	0.00017	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—hematologic cancer	5.97e-05	0.000169	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—hematologic cancer	5.89e-05	0.000166	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—hematologic cancer	5.88e-05	0.000166	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—hematologic cancer	5.87e-05	0.000166	CcSEcCtD
Tetrabenazine—Vomiting—Prednisone—hematologic cancer	5.8e-05	0.000164	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—hematologic cancer	5.74e-05	0.000162	CcSEcCtD
Tetrabenazine—Headache—Prednisone—hematologic cancer	5.72e-05	0.000162	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—hematologic cancer	5.69e-05	0.000161	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—hematologic cancer	5.65e-05	0.00016	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—hematologic cancer	5.64e-05	0.00016	CcSEcCtD
Tetrabenazine—Asthenia—Methotrexate—hematologic cancer	5.47e-05	0.000155	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—hematologic cancer	5.44e-05	0.000154	CcSEcCtD
Tetrabenazine—Nausea—Prednisone—hematologic cancer	5.42e-05	0.000153	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—hematologic cancer	5.22e-05	0.000148	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—hematologic cancer	5.22e-05	0.000148	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—hematologic cancer	5.12e-05	0.000145	CcSEcCtD
Tetrabenazine—Dizziness—Methotrexate—hematologic cancer	5.04e-05	0.000143	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—hematologic cancer	4.88e-05	0.000138	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—hematologic cancer	4.85e-05	0.000137	CcSEcCtD
Tetrabenazine—Headache—Methotrexate—hematologic cancer	4.78e-05	0.000135	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—hematologic cancer	4.74e-05	0.000134	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—hematologic cancer	4.72e-05	0.000133	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—hematologic cancer	4.54e-05	0.000128	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—hematologic cancer	4.53e-05	0.000128	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—hematologic cancer	4.47e-05	0.000126	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—hematologic cancer	4.37e-05	0.000123	CcSEcCtD
Tetrabenazine—Nausea—Epirubicin—hematologic cancer	4.24e-05	0.00012	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—hematologic cancer	4.2e-05	0.000119	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—hematologic cancer	4.14e-05	0.000117	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—hematologic cancer	3.92e-05	0.000111	CcSEcCtD
Tetrabenazine—CYP2D6—Metabolism—PHYH—hematologic cancer	3.18e-05	0.000693	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GMPS—hematologic cancer	3.18e-05	0.000693	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BCR—hematologic cancer	3.16e-05	0.000688	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PDE4B—hematologic cancer	3.14e-05	0.000685	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CNR2—hematologic cancer	3.14e-05	0.000685	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—LPAR1—hematologic cancer	3.1e-05	0.000676	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—RAC2—hematologic cancer	3.09e-05	0.000674	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3R1—hematologic cancer	3.09e-05	0.000674	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—hematologic cancer	2.97e-05	0.000648	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADCY7—hematologic cancer	2.95e-05	0.000644	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HDAC10—hematologic cancer	2.94e-05	0.00064	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—JUN—hematologic cancer	2.93e-05	0.000639	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.91e-05	0.000634	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PDE4B—hematologic cancer	2.85e-05	0.000622	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CNR2—hematologic cancer	2.85e-05	0.000622	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CB—hematologic cancer	2.85e-05	0.000622	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—hematologic cancer	2.84e-05	0.000618	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RAC2—hematologic cancer	2.81e-05	0.000612	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	2.8e-05	0.00061	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—MAPK8—hematologic cancer	2.77e-05	0.000605	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EP300—hematologic cancer	2.7e-05	0.00059	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ARHGEF12—hematologic cancer	2.68e-05	0.000585	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADCY7—hematologic cancer	2.68e-05	0.000585	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTHLH—hematologic cancer	2.67e-05	0.000583	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ARHGEF1—hematologic cancer	2.62e-05	0.00057	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTGER4—hematologic cancer	2.6e-05	0.000567	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DCK—hematologic cancer	2.54e-05	0.000554	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ASNS—hematologic cancer	2.54e-05	0.000554	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.54e-05	0.000554	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—hematologic cancer	2.46e-05	0.000537	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCL3—hematologic cancer	2.45e-05	0.000535	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTHLH—hematologic cancer	2.43e-05	0.000529	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HDC—hematologic cancer	2.41e-05	0.000525	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTGER4—hematologic cancer	2.36e-05	0.000515	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—EP300—hematologic cancer	2.35e-05	0.000512	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGRN—hematologic cancer	2.35e-05	0.000512	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL17—hematologic cancer	2.35e-05	0.000512	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCR5—hematologic cancer	2.3e-05	0.000502	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCR4—hematologic cancer	2.3e-05	0.000501	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEF1—hematologic cancer	2.26e-05	0.000493	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNA13—hematologic cancer	2.22e-05	0.000485	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL3—hematologic cancer	2.22e-05	0.000483	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CDA—hematologic cancer	2.2e-05	0.00048	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TIAM1—hematologic cancer	2.19e-05	0.000477	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—RASGRP1—hematologic cancer	2.14e-05	0.000467	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCL2—hematologic cancer	2.13e-05	0.000465	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAK3—hematologic cancer	2.12e-05	0.000463	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PC—hematologic cancer	2.12e-05	0.000462	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCR4—hematologic cancer	2.09e-05	0.000455	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GBA—hematologic cancer	2.05e-05	0.000446	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.05e-05	0.000446	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCR7—hematologic cancer	2.03e-05	0.000444	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL13—hematologic cancer	2.03e-05	0.000444	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL3—hematologic cancer	2.01e-05	0.000439	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NCOR2—hematologic cancer	2.01e-05	0.000438	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CRKL—hematologic cancer	1.98e-05	0.000432	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL3RA—hematologic cancer	1.98e-05	0.000432	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RASGRP1—hematologic cancer	1.95e-05	0.000424	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—hematologic cancer	1.94e-05	0.000422	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRB2—hematologic cancer	1.93e-05	0.00042	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RGS2—hematologic cancer	1.91e-05	0.000417	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CMA1—hematologic cancer	1.89e-05	0.000412	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TRIO—hematologic cancer	1.89e-05	0.000412	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TRH—hematologic cancer	1.89e-05	0.000412	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.87e-05	0.000408	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SPHK1—hematologic cancer	1.85e-05	0.000404	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGO2—hematologic cancer	1.85e-05	0.000404	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HDAC9—hematologic cancer	1.83e-05	0.000399	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LPAR1—hematologic cancer	1.83e-05	0.000399	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—H3F3B—hematologic cancer	1.81e-05	0.000395	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—hematologic cancer	1.77e-05	0.000386	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRB2—hematologic cancer	1.75e-05	0.000382	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—hematologic cancer	1.74e-05	0.000379	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CSF2—hematologic cancer	1.72e-05	0.000375	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDE4B—hematologic cancer	1.69e-05	0.000368	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CNR2—hematologic cancer	1.69e-05	0.000368	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF19—hematologic cancer	1.67e-05	0.000365	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.67e-05	0.000364	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PRKCG—hematologic cancer	1.66e-05	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—JAK1—hematologic cancer	1.66e-05	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAC2—hematologic cancer	1.66e-05	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DKK1—hematologic cancer	1.65e-05	0.000359	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.64e-05	0.000357	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT5B—hematologic cancer	1.63e-05	0.000356	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADCY7—hematologic cancer	1.58e-05	0.000346	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CSF2—hematologic cancer	1.56e-05	0.000341	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2RA—hematologic cancer	1.55e-05	0.000338	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.55e-05	0.000338	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.55e-05	0.000338	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—XIAP—hematologic cancer	1.54e-05	0.000336	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRKCG—hematologic cancer	1.51e-05	0.000329	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—JAK1—hematologic cancer	1.51e-05	0.000329	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SH2B3—hematologic cancer	1.5e-05	0.000328	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SMARCA4—hematologic cancer	1.5e-05	0.000328	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GZMB—hematologic cancer	1.49e-05	0.000326	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.46e-05	0.000318	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNA1—hematologic cancer	1.46e-05	0.000318	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.45e-05	0.000316	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL3—hematologic cancer	1.45e-05	0.000316	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HSPB1—hematologic cancer	1.45e-05	0.000316	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTHLH—hematologic cancer	1.43e-05	0.000313	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SDC1—hematologic cancer	1.43e-05	0.000313	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—hematologic cancer	1.42e-05	0.00031	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.42e-05	0.000309	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CA9—hematologic cancer	1.42e-05	0.000309	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2RA—hematologic cancer	1.41e-05	0.000307	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.4e-05	0.000305	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTGER4—hematologic cancer	1.4e-05	0.000304	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LCK—hematologic cancer	1.39e-05	0.000303	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—H3F3A—hematologic cancer	1.36e-05	0.000297	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.33e-05	0.000291	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCZ—hematologic cancer	1.32e-05	0.000288	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.32e-05	0.000288	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.32e-05	0.000288	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TXN—hematologic cancer	1.32e-05	0.000288	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.29e-05	0.000282	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.29e-05	0.000282	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PARP1—hematologic cancer	1.28e-05	0.000279	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FBXW7—hematologic cancer	1.26e-05	0.000274	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.24e-05	0.00027	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCR4—hematologic cancer	1.23e-05	0.000269	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HDAC2—hematologic cancer	1.23e-05	0.000269	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.21e-05	0.000263	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.21e-05	0.000263	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CBL—hematologic cancer	1.2e-05	0.000262	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL3—hematologic cancer	1.19e-05	0.000259	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.18e-05	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—hematologic cancer	1.17e-05	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTPN1—hematologic cancer	1.17e-05	0.000255	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTPN11—hematologic cancer	1.15e-05	0.000252	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RASGRP1—hematologic cancer	1.15e-05	0.000251	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SYK—hematologic cancer	1.15e-05	0.00025	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HSP90AA1—hematologic cancer	1.15e-05	0.00025	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.14e-05	0.000248	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.14e-05	0.000248	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CREB1—hematologic cancer	1.12e-05	0.000244	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.11e-05	0.000241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.11e-05	0.000241	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT1—hematologic cancer	1.1e-05	0.000241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NUP214—hematologic cancer	1.1e-05	0.000239	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCL2—hematologic cancer	1.09e-05	0.000238	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6R—hematologic cancer	1.09e-05	0.000238	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.08e-05	0.000235	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTR—hematologic cancer	1.08e-05	0.000235	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.07e-05	0.000234	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENO2—hematologic cancer	1.05e-05	0.00023	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—JAK2—hematologic cancer	1.04e-05	0.000227	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAP2K1—hematologic cancer	1.04e-05	0.000227	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRB2—hematologic cancer	1.03e-05	0.000225	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—hematologic cancer	1.03e-05	0.000225	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFA—hematologic cancer	1.03e-05	0.000225	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.02e-05	0.000223	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KITLG—hematologic cancer	1.02e-05	0.000222	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SDC1—hematologic cancer	1e-05	0.000218	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT5A—hematologic cancer	9.94e-06	0.000217	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—hematologic cancer	9.91e-06	0.000216	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN2B—hematologic cancer	9.85e-06	0.000215	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3R1—hematologic cancer	9.75e-06	0.000213	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CD86—hematologic cancer	9.53e-06	0.000208	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—JAK2—hematologic cancer	9.47e-06	0.000207	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HES1—hematologic cancer	9.4e-06	0.000205	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NCOR1—hematologic cancer	9.34e-06	0.000204	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF1—hematologic cancer	9.24e-06	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CSF2—hematologic cancer	9.24e-06	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FOXO1—hematologic cancer	9.1e-06	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—hematologic cancer	9.1e-06	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFRB—hematologic cancer	9.09e-06	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—hematologic cancer	9e-06	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFRA—hematologic cancer	8.95e-06	0.000195	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAK1—hematologic cancer	8.92e-06	0.000194	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCG—hematologic cancer	8.92e-06	0.000194	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—hematologic cancer	8.5e-06	0.000185	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CD44—hematologic cancer	8.5e-06	0.000185	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2RA—hematologic cancer	8.33e-06	0.000182	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—hematologic cancer	8.26e-06	0.00018	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—hematologic cancer	8.23e-06	0.000179	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYCS—hematologic cancer	8.05e-06	0.000175	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFB—hematologic cancer	8.04e-06	0.000175	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	7.99e-06	0.000174	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TSC2—hematologic cancer	7.85e-06	0.000171	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR3—hematologic cancer	7.55e-06	0.000165	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK14—hematologic cancer	7.48e-06	0.000163	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—hematologic cancer	7.34e-06	0.00016	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FN1—hematologic cancer	7.25e-06	0.000158	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BAD—hematologic cancer	7.16e-06	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	7.16e-06	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	7.09e-06	0.000155	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.09e-06	0.000155	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CD80—hematologic cancer	6.95e-06	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	6.94e-06	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KIT—hematologic cancer	6.94e-06	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—NRAS—hematologic cancer	6.94e-06	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTPN11—hematologic cancer	6.81e-06	0.000149	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.71e-06	0.000146	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	6.64e-06	0.000145	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CREB1—hematologic cancer	6.6e-06	0.000144	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BRAF—hematologic cancer	6.52e-06	0.000142	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.52e-06	0.000142	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.52e-06	0.000142	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL2—hematologic cancer	6.46e-06	0.000141	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6R—hematologic cancer	6.44e-06	0.00014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	6.43e-06	0.00014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	6.14e-06	0.000134	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	6.1e-06	0.000133	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	6.04e-06	0.000132	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	5.97e-06	0.00013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF2—hematologic cancer	5.84e-06	0.000127	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.76e-06	0.000126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	5.76e-06	0.000126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAK2—hematologic cancer	5.6e-06	0.000122	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	5.48e-06	0.00012	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MDM2—hematologic cancer	5.46e-06	0.000119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTOR—hematologic cancer	5.31e-06	0.000116	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	5.31e-06	0.000116	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	5.07e-06	0.000111	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	4.99e-06	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	4.93e-06	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—hematologic cancer	4.89e-06	0.000107	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—hematologic cancer	4.88e-06	0.000106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—hematologic cancer	4.86e-06	0.000106	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.84e-06	0.000105	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—hematologic cancer	4.76e-06	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUN—hematologic cancer	4.75e-06	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	4.6e-06	0.0001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—hematologic cancer	4.59e-06	0.0001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	4.49e-06	9.8e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.49e-06	9.78e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	4.48e-06	9.77e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EP300—hematologic cancer	4.38e-06	9.55e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—hematologic cancer	4.26e-06	9.29e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.25e-06	9.27e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—hematologic cancer	4.2e-06	9.16e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	4.15e-06	9.04e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	4.11e-06	8.96e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	4.1e-06	8.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.02e-06	8.76e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	3.92e-06	8.56e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—hematologic cancer	3.82e-06	8.32e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	3.81e-06	8.3e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.71e-06	8.08e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	3.53e-06	7.69e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	3.24e-06	7.06e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.2e-06	6.99e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—hematologic cancer	3.13e-06	6.83e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EP300—hematologic cancer	3.06e-06	6.66e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	3e-06	6.54e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—hematologic cancer	2.87e-06	6.26e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	2.65e-06	5.77e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.26e-06	4.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.85e-06	4.03e-05	CbGpPWpGaD
